DE69332275D1 - Verfahren und zusammensetzungen auf der basis eines polymers (poloxamer) zur zellregeneration - Google Patents
Verfahren und zusammensetzungen auf der basis eines polymers (poloxamer) zur zellregenerationInfo
- Publication number
- DE69332275D1 DE69332275D1 DE69332275T DE69332275T DE69332275D1 DE 69332275 D1 DE69332275 D1 DE 69332275D1 DE 69332275 T DE69332275 T DE 69332275T DE 69332275 T DE69332275 T DE 69332275T DE 69332275 D1 DE69332275 D1 DE 69332275D1
- Authority
- DE
- Germany
- Prior art keywords
- surface active
- disclosed
- compositions
- methods
- active copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/835,271 US5470568A (en) | 1992-02-13 | 1992-02-13 | Methods and compositions of a polymer (poloxamer) for cell repair |
PCT/US1993/001327 WO1993015745A1 (en) | 1992-02-13 | 1993-02-12 | Methods and compositions of a polymer (poloxamer) for cell repair |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69332275D1 true DE69332275D1 (de) | 2002-10-10 |
DE69332275T2 DE69332275T2 (de) | 2003-04-17 |
Family
ID=25269083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332275T Expired - Lifetime DE69332275T2 (de) | 1992-02-13 | 1993-02-12 | Verfahren und zusammensetzungen auf der basis eines polymers (poloxamer) zur zellregeneration |
Country Status (7)
Country | Link |
---|---|
US (1) | US5470568A (de) |
EP (1) | EP0683669B1 (de) |
AT (1) | ATE223222T1 (de) |
AU (1) | AU3667293A (de) |
DE (1) | DE69332275T2 (de) |
DK (1) | DK0683669T3 (de) |
WO (1) | WO1993015745A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020123476A1 (en) * | 1991-03-19 | 2002-09-05 | Emanuele R. Martin | Therapeutic delivery compositions and methods of use thereof |
US7202225B1 (en) * | 1993-10-15 | 2007-04-10 | Emanuele R Martin | Therapeutic delivery compositions and methods of use thereof |
US6153193A (en) * | 1993-04-28 | 2000-11-28 | Supratek Pharma Inc. | Compositions for targeting biological agents |
US6093391A (en) * | 1992-10-08 | 2000-07-25 | Supratek Pharma, Inc. | Peptide copolymer compositions |
US6277410B1 (en) | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
US5608520A (en) * | 1994-07-11 | 1997-03-04 | The United States Of America As Represented By He Department Of Energy | Plasma emission spectroscopy method of tumor therapy |
GB9417742D0 (en) * | 1994-09-03 | 1994-10-19 | Univ Nottingham | Macrophage stimulating composition |
US6353055B1 (en) | 1994-11-18 | 2002-03-05 | Supratek Pharma Inc. | Polynucleotide compositions |
US6221959B1 (en) | 1994-11-18 | 2001-04-24 | Supratek Pharma, Inc. | Polynucleotide compositions |
US6359054B1 (en) | 1994-11-18 | 2002-03-19 | Supratek Pharma Inc. | Polynucleotide compositions for intramuscular administration |
US6040295A (en) | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
DE19537494C2 (de) * | 1995-09-25 | 1997-10-02 | Desitin Arzneimittel Gmbh | Kreatin zum Schutz von neuralem Gewebe |
US6323549B1 (en) * | 1996-08-29 | 2001-11-27 | L. Pierre deRochemont | Ceramic composite wiring structures for semiconductor devices and method of manufacture |
WO1998013069A2 (en) | 1996-09-09 | 1998-04-02 | Supratek Pharma, Inc. | Fluorinated copolymeric pharmaceutical adjuncts |
WO2000009732A1 (en) * | 1998-08-13 | 2000-02-24 | Warner-Lambert Company | Electroporation buffer with cryprotective capabilities |
US7582680B1 (en) | 1998-11-12 | 2009-09-01 | Purdue Research Foundation | Methods and compositions for treating mammalian spinal cord injuries |
EP1309904A4 (de) * | 2000-03-03 | 2006-03-29 | Valentis Inc | Verbesserte poloxamer- und polyoaminverbindungen zur nukleinsäureeinbringung |
EP1278551A2 (de) * | 2000-04-21 | 2003-01-29 | Vical Incorporated | Zusammensetzungen und verfahren zur (in vivo) verabreichung der auf polynukleotiden-basierenden therapeutika |
WO2001083698A2 (en) * | 2000-04-28 | 2001-11-08 | Supratek Pharma, Inc. | Compositions and methods for inducing activation of dendritic cells |
MY128134A (en) * | 2000-09-28 | 2007-01-31 | Novartis Ag | Compositions and methods for cleaning contact lenses |
US20040009940A1 (en) * | 2000-10-20 | 2004-01-15 | Coleman Michael E. | Gene delivery formulations and methods for treatment of ischemic conditions |
CA2445612C (en) | 2001-04-24 | 2011-10-25 | Purdue Research Foundation | Methods and compositions for treating mammalian nerve tissue injuries |
CA2472170A1 (en) * | 2001-12-28 | 2003-07-24 | Supratek Pharma Inc. | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
FR2835749B1 (fr) * | 2002-02-08 | 2006-04-14 | Inst Nat Sante Rech Med | Composition pharmaceutique ameliorant le transfert de gene in vivo |
KR101198550B1 (ko) | 2003-03-24 | 2012-11-06 | 플루로메드, 인코포레이티드 | 역성 열감응 중합체를 사용하는 일시적인 색전화 |
WO2005046438A2 (en) * | 2003-11-06 | 2005-05-26 | Pluromed, Inc. | Internal clamp for surgical procedures |
US20090155200A1 (en) * | 2004-04-20 | 2009-06-18 | Jay Gregory D | Methods of promoting cartilage healing or cartilage integration |
WO2006044738A2 (en) * | 2004-10-18 | 2006-04-27 | Maroon Biotech Corporation | Methods and compositions for treatment of free radical injury |
WO2008034082A2 (en) * | 2006-09-15 | 2008-03-20 | Maroon Biotech, Corporation | Method of using amphiphilic multiblock copolymers in food |
EP3170396A1 (de) | 2007-02-19 | 2017-05-24 | Plurogen Therapeutics, Inc. | Zusammensetzungen zur bearbeitung von biofolien und verfahren zur verwendung davon |
BRPI0919919A2 (pt) | 2008-10-21 | 2017-05-30 | Massachusetts Gen Hospital | transplante celular |
WO2012019103A2 (en) | 2010-08-06 | 2012-02-09 | The General Hospital Corporation D/B/A | System and apparatus for cell treatment |
US20160131634A1 (en) * | 2013-05-29 | 2016-05-12 | Biogen Ma Inc. | Methods of evaluating cell culture additives |
WO2016118644A1 (en) * | 2015-01-20 | 2016-07-28 | Plurogen Therapeutics, Llc | Compositions and methods of treating microbes |
JP2023532915A (ja) * | 2020-07-09 | 2023-08-01 | ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント | 傷害から細胞を保護する方法 |
US20240024354A1 (en) * | 2020-09-04 | 2024-01-25 | The University Of Chicago | Materials and methods of treating viral infection with amphiphilic block copolymers |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US29909A (en) * | 1860-09-04 | Ebenezer G Pomeroy | Improved method of converting iron into steel | |
US2674619A (en) * | 1953-10-19 | 1954-04-06 | Wyandotte Chemicals Corp | Polyoxyalkylene compounds |
US2854378A (en) * | 1955-12-08 | 1958-09-30 | Bristol Lab Inc | Tetracycline suppository |
GB840155A (en) * | 1958-01-30 | 1960-07-06 | Louis Lafon | Improvements in or relating to pharmaceutical compositions |
US3089818A (en) * | 1960-06-02 | 1963-05-14 | Baxter Laboratories Inc | Water dispersible antibiotics |
GB983130A (en) * | 1962-08-06 | 1965-02-10 | Mundipharma Ag | Improvements in preparations for the removal of wax from the ear |
US3140232A (en) * | 1962-12-19 | 1964-07-07 | Pfizer & Co C | Color stabilization of tetracycline compositions with polypropylene glycols |
US3740421A (en) * | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
US3639575A (en) * | 1968-06-19 | 1972-02-01 | Basf Wyandotte Corp | Silver ion gel compositions and method of using the same |
AU418761B2 (en) * | 1968-09-19 | 1971-11-06 | Phosiological salt solutions of ethylene oxide-polypropylene glycol condensation products | |
US3641240A (en) * | 1968-09-27 | 1972-02-08 | Wyandotte Chemicals Corp | Method for the treatment of an embolus or thrombus |
US3590125A (en) * | 1969-10-10 | 1971-06-29 | Wyandotte Chemicals Corp | Physiological salt solutions of ethylene oxide-polypropylene glycol condensation products as blood plasma substitutes |
US3577522A (en) * | 1969-10-10 | 1971-05-04 | Wyandotte Chemicals Corp | Methods for the treatment of shock with ethylene oxide-polypropylene glycol condensates as blood plasma substitutes |
US3980772A (en) * | 1969-12-02 | 1976-09-14 | Baxter Laboratories, Inc. | Methods of dissolving blood clots and the like with streptokinase chemically bonded to a carbohydrate matrix |
US3867521A (en) * | 1970-08-26 | 1975-02-18 | Scherer Corp R P | Method for absorption of drugs |
US3956259A (en) * | 1973-01-30 | 1976-05-11 | Baxter Laboratories, Inc. | Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate |
US4073886A (en) * | 1973-01-30 | 1978-02-14 | Baxter Travenol Laboratories, Inc. | Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US3997458A (en) * | 1974-04-12 | 1976-12-14 | Deknatel, Incorporated | Method of cleansing contaminated wounds and surgical scrub solutions for same |
US4105650A (en) * | 1975-04-11 | 1978-08-08 | Edward Shanbrom, Inc. | Method of preserving blood plasma i |
US4100271A (en) * | 1976-02-26 | 1978-07-11 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4305922A (en) * | 1978-10-04 | 1981-12-15 | University Patents, Inc. | Labeling proteins with 99m-Tc by ligand exchange |
US4186253A (en) * | 1978-10-10 | 1980-01-29 | The Green Cross Corporation | Perfusate for preserving organ to be transplanted and preserving method |
US4395393A (en) * | 1981-08-10 | 1983-07-26 | Basf Wyandotte Corporation | Artificial blood emulsifiers |
US4407790A (en) * | 1981-09-25 | 1983-10-04 | Economics Laboratory, Inc. | Method of controlling bloat using nonionic surfactants |
CA1244774A (en) * | 1983-11-09 | 1988-11-15 | Thomas Jefferson University | Medium for storing blood platelets |
US4600652A (en) * | 1985-04-01 | 1986-07-15 | Warner-Lambert Company | Permanently bonded antithrombogenic polyurethane surface |
JPH084504B2 (ja) * | 1985-04-26 | 1996-01-24 | 味の素株式会社 | 安定化ス−パ−オキサイドジスムタ−ゼ |
WO1987006831A1 (en) * | 1986-05-15 | 1987-11-19 | Emory University | Composition and method for treating a thrombus and embolus |
US5032394A (en) * | 1986-05-15 | 1991-07-16 | Emory University | Method of treating burns |
US4897263A (en) * | 1986-05-15 | 1990-01-30 | Emory University | Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
US4937070A (en) * | 1986-05-15 | 1990-06-26 | Emory University | Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
US4879109A (en) * | 1986-05-15 | 1989-11-07 | Emory University | Method for treating burns |
US5017370A (en) * | 1986-05-15 | 1991-05-21 | Emory University | Improved method of performing angioplasty procedures |
US5064643A (en) * | 1986-05-15 | 1991-11-12 | Emory University | Method for treating sickle cell disease |
US5047236A (en) * | 1986-05-15 | 1991-09-10 | Emory University | Method of treating stroke |
US4801452A (en) * | 1986-05-15 | 1989-01-31 | Hunter Robert L | Fibrinolytic composition |
US4873083A (en) * | 1986-05-15 | 1989-10-10 | Emory University | Fibrinolytic composition |
US5039520A (en) * | 1986-05-15 | 1991-08-13 | Emory University | Plasma extender |
US4837014A (en) * | 1986-05-15 | 1989-06-06 | Emory University | An improved method of treating sickle cell anemia |
US5089260A (en) * | 1986-05-15 | 1992-02-18 | Emory University | Method of treating ischemic tissue |
US5028599A (en) * | 1986-05-15 | 1991-07-02 | Emory University | Method of treating mycardial damage |
WO1987006836A1 (en) * | 1986-05-15 | 1987-11-19 | Emory University | Fibrinolytic composition |
US5080894A (en) * | 1986-05-15 | 1992-01-14 | Emory University | Method and composition for reducing tissue damage |
US5078995A (en) * | 1986-05-15 | 1992-01-07 | Emory University | Fibrionolytic composition |
US5030448A (en) * | 1986-05-15 | 1991-07-09 | Emory University | Method of delivering drugs to damaged or diseased tissue |
US5152979A (en) * | 1986-05-15 | 1992-10-06 | Emory University | Method for treating vascular obstructions caused by abnormal cells |
US5071649A (en) * | 1986-05-15 | 1991-12-10 | Emory University | Method of preventing blockage in catheters |
US5041288A (en) * | 1986-05-15 | 1991-08-20 | Emory University | Method of treating tissue damaged by reperfusion injury |
US5045468A (en) * | 1986-12-12 | 1991-09-03 | Cell Enterprises, Inc. | Protein-free culture medium which promotes hybridoma growth |
US5075333A (en) * | 1987-08-19 | 1991-12-24 | Hoffmann-La Roche Inc. | Tetrahydronaphthalene and indane compounds useful for reversing the photo-damage in sun-exposed skin |
US5002965A (en) * | 1989-05-09 | 1991-03-26 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Use of ginkgolides to prevent reperfusion injury in organ transplantation |
US4997664A (en) * | 1989-09-05 | 1991-03-05 | Bryan Foods, Inc. | Method for packaging food products |
-
1992
- 1992-02-13 US US07/835,271 patent/US5470568A/en not_active Expired - Lifetime
-
1993
- 1993-02-12 EP EP93905944A patent/EP0683669B1/de not_active Expired - Lifetime
- 1993-02-12 AU AU36672/93A patent/AU3667293A/en not_active Abandoned
- 1993-02-12 DK DK93905944T patent/DK0683669T3/da active
- 1993-02-12 WO PCT/US1993/001327 patent/WO1993015745A1/en active IP Right Grant
- 1993-02-12 DE DE69332275T patent/DE69332275T2/de not_active Expired - Lifetime
- 1993-02-12 AT AT93905944T patent/ATE223222T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE223222T1 (de) | 2002-09-15 |
AU3667293A (en) | 1993-09-03 |
DE69332275T2 (de) | 2003-04-17 |
EP0683669A4 (de) | 1995-08-11 |
US5470568A (en) | 1995-11-28 |
DK0683669T3 (da) | 2003-01-06 |
WO1993015745A1 (en) | 1993-08-19 |
EP0683669A1 (de) | 1995-11-29 |
EP0683669B1 (de) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE223222T1 (de) | Verfahren und zusammensetzungen auf der basis eines polymers (poloxamer) zur zellregeneration | |
Matsumoto et al. | Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor | |
MX9306029A (es) | Composiciones protectoras y regenerativas de tejidos. | |
Ribeiro et al. | Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds | |
CA2402650A1 (en) | Resorbable barrier micro-membranes for attenuation of scar tissue during healing | |
NO953093D0 (no) | Forbindelser med både sterk kalsiumantagonist- og antioksidantvirkning, samt anvendelse derav som cellebeskyttende midler | |
EA200600076A1 (ru) | Композиции и способы увеличения активности теломеразы | |
CA2387542A1 (en) | Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation | |
Kovacsovics-Bankowski et al. | Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease | |
CA2147123A1 (en) | Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo | |
MX2009012742A (es) | Ingrediente activo novedoso en cicatrizacion y uso del mismo. | |
NZ506631A (en) | Formulations for the stabilisation of PEG-interferon alpha conjugates during and after lyophilization | |
WO1994006449A3 (en) | Morphogen-induced liver regeneration | |
FI951997A (fi) | Nukleiinihappojen hajotus peroksideilla | |
DK0952772T3 (da) | Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration | |
EA200501828A1 (ru) | Тканепротекторные цитокины с увеличенным терапевтическим окном для защиты, восстановления и стимулирования реагирующих клеток, тканей и органов | |
AU1300783A (en) | Sulphate esters of vinyl alcohol polymers | |
WO2003033678A3 (en) | Methods of using deacetylase inhibitors to promote cell differentiation and regeneration | |
AU5323396A (en) | Methods of treating inflammation and compositions therefor | |
AU6505394A (en) | Tumoricide t lymphocytes | |
EP0641201A4 (de) | Erzeugung extrinsischer hautalterung durch transdermale anwendung von selenaminosäuren. | |
CN104651303A (zh) | 一种汗腺细胞匀浆液诱导骨髓间充质干细胞转变为汗腺样细胞的方法 | |
ATE391508T1 (de) | Zusammensetzungen mit amphotericin b enthaltend weniger als 4 verunreinigungen | |
CA2255748A1 (en) | Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders | |
ES2175449T3 (es) | Procedimiento para la desactivacion de virus envueltos por lipidos, con lipopeptidos, y nuevos lipopeptidos antiviricos. |